Skip to content

CIRCumcision and Urinary Tract Infections in Boys With Posterior Urethral Valves

Effect of Circumcision on the Risk of Febrile Urinary Tract Infections in Children With Posterior Urethral Valves.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01537601
Acronym
CIRCUP
Enrollment
92
Registered
2012-02-23
Start date
2012-08-31
Completion date
2019-02-18
Last updated
2023-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Posterior Urethral Valves

Keywords

Posterior urethral valves, Febrile urinary tract infection, Circumcision, Antibioprophylaxis, Impact on family

Brief summary

Children with posterior urethral valves (PUV) are at risk of presenting febrile urinary tract infections (UTI). Circumcision has been shown to decrease the number of febrile UTIs in healthy children. The effect of circumcision on the number of UTIs in boys with PUV has not yet been studied. Through a prospective randomised trial of children with posterior urethral valves the investigators wish to determine the effect of circumcision on the risk of presenting febrile UTIs. One group will be on antibiotic prophylaxis alone and the other will be on antibiotic prophylaxis plus circumcision performed at the time of valve resection. Both groups will be followed for two years, with clinical examination at 1, 3, 6, 12, 18 and 24 months. A DMSA scan will be performed at 1-2 and 24 months and biological renal function will also be monitored. The relative risk of presenting a febrile UTI in each group will be determined. Clinical, radiological and antenatal data concerning each child will be analysed. At 24 months follow-up, an impact on family scale survey (IOFS) will be proposed parents.

Detailed description

After diagnosis of posterior urethral valves, children will be randomised either to antibioprophylaxis alone or antibioprophylaxis plus circumcision. Circumcision will be performed at the time of valve resection. Children will undergo a cystogram between 1 and 4 months to control valve resection. They will be followed for two years and the number of febrile UTIs in each group will be compared. The diagnosis of febrile UTI will be confirmed by urethral catheterisation or suprapubic aspiration. A DMSA scan will be performed at the beginning and end of the study to determine whether children who have presented febrile UTIs show deterioration of their DMSA as compared to those who did not present febrile UTIs. At 24 months follow-up, impact on family scale survey (IOFS) whose main objective is to evaluate the impact of family support for a child with posterior urethral valves will be proposed parents.

Interventions

PROCEDURECircumcision

Circumcision

OTHERAntibiotic prophylaxis alone

Antibiotic prophylaxis alone

Sponsors

Centre Hospitalier Universitaire de la Réunion
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
No minimum to 28 Days
Healthy volunteers
No

Inclusion criteria

* male * aged 0 to 28 days * diagnosed with posterior urethral valves within the 28 first day of life * holders of parental authority affiliated to French national health insurance * informed consent signed by holders of parental authority

Exclusion criteria

* boys with hypospadias or epispadias or any other anomaly rendering circumcision impossible * concomitant participation to another clinical trial

Design outcomes

Primary

MeasureTime frame
Relative risk of presenting a febrile UTI24 months

Secondary

MeasureTime frame
Evolution of compliance to antibioprophylaxis.24 months
Evolution of the grade of refluxAt diagnosis and at 3 months
Number of children with febrile UTIs in each group at two years24 months
number and type of adverse effects related to circumcision and antibiotic prophylaxis24 months
Identification of the responsible bacteria24 months
Comparison of the number of children who will show deterioration of their DMSA scan between children who have had UTIs and those who have not.24 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026